{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:31:53Z","timestamp":1791433913684,"version":"4.3.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.5664\/jcsm.10946","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T14:01:56Z","timestamp":1702044116000},"page":"603-613","source":"Crossref","is-referenced-by-count":17,"title":["A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists"],"prefix":"10.1007","volume":"20","author":[{"given":"Masumi","family":"Tachibana","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan"},{"name":"Safety and Health Organization, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Kanahara","sequence":"additional","affiliation":[{"name":"Division of Medical Treatment and Rehabilitation, Chiba University Center for Forensic Mental Health, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan"},{"name":"Chiba University Hospital Palliative Care Center, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04418.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-015-0642-5"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000506868"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-021-00244-9"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12594"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000434755"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3031"},{"issue":"1","key":"e_1_3_2_11_2","first-page":"43","article-title":"Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines","volume":"129","author":"Lee JY","year":"2019","unstructured":"Lee JY , Farrell B , Holbrook AM . Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines . Pol Arch Intern Med. 2019 ; 129 ( 1 ): 43 \u2013 49 .","journal-title":"Pol Arch Intern Med."},{"issue":"5","key":"e_1_3_2_12_2","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie K","year":"2018","unstructured":"Pottie K , Thompson W , Davies S , et\u00a0al . Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline . Can Fam Physician. 2018 ; 64 ( 5 ): 339 \u2013 351 .","journal-title":"Can Fam Physician."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072493"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03563.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02364.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2017.1423030"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1817380"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.12793\/tcp.2022.30.e21"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.05.025"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.21011"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00878-9"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13795"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1037\/bul0000053"},{"key":"e_1_3_2_24_2","unstructured":"Inagaki A Inada T . Equivalent dose of anxiolytic and hypnotic agents. 2015 . The Japanese Society of Psychiatric Rating Scales. In Japanese. http:\/\/jsprs.org\/toukakansan\/2017ver\/antianxiety-hypnotic.php . Accessed February 1 2023."},{"key":"e_1_3_2_25_2","unstructured":"Inagaki A Inada T . Equivalent dose of anxiolytic and hypnotic agents. 2017 . The Japanese Society of Psychiatric Rating Scales. In Japanese. http:\/\/jsprs.org\/toukakansan\/2017ver\/oral_antpsychotic.php . Accessed February 1 2023."},{"key":"e_1_3_2_26_2","unstructured":"Inagaki A Inada T . Equivalent dose of antidepressants. 2017 . The Japanese Society of Psychiatric Rating Scales. In Japanese. http:\/\/jsprs.org\/toukakansan\/2017ver\/antidepressants.php . Accessed February 1 2023."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2007.09.004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12865"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-019-1297-6"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2868"},{"key":"e_1_3_2_31_2","unstructured":"MSD K.K . Interview form of suvorexant (Belsomra) 20mg\/15mg\/10mg. Revised in September 2023 (version 13). eEref. In Japanese. https:\/\/www.msdconnect.jp\/wp-content\/uploads\/sites\/5\/2022\/01\/if_belsomra_tab.pdf. Accessed September 30 2023."},{"key":"e_1_3_2_32_2","unstructured":"Eisai Co. Ltd . Interview form of lemborexant (Dayvigo) 2.5mg\/5mg\/10mg. Revised in October 2023 (version 8). eEref. In Japanese. https:\/\/medical2.eisai.jp\/fileviewer\/pdf_downloader.php?access_key=o3nysuvlsa. Accessed October 30 2023."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.817"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12205"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101573"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(85)90038-7"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2014.50"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:05:21Z","timestamp":1770109521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.10946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.5664\/jcsm.10946"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.10946","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}